The recent court ruling on Ivermectin USA has sent ripples through the healthcare and legal communities. This landmark decision redefines the legal landscape surrounding access to repurposed drugs like Ivermectin, which gained attention during the COVID-19 pandemic for potential off-label use. For many Americans, this ruling impacts patient rights, pharmacy dispensing, and state authority over […]
